BECTON DICKINSON -
ORGANIZATIONAL BACKGROUND
Group Members
Hardik Gandhi Roll No. 8
Sneha Mhatre Roll No. 19
Kingslin Nadar Roll No. 21
Sandeep Nair Roll No. 23
Sumit Panjwani Roll No. 26
KINGSLIN NADAR ROLL NO. 21
AGENDA
Key Takeaways
DRBC Model
Issues
SWOT Analysis
Mr. Clateo Castellini and his concerns
About the Company
ABOUT THE COMPANY
Founded in 1897 by Maxwell W. Becton & Fairleigh S. Dickinson
Initially as an importer of Medical devices
Later emerged as a major manufacturer of medical supplies & diagnostic equipment.
First manufacturer of modern stethoscope, insulin syringe and vacuum tubes
Headquartered in Franklin Lakes, New Jersey, U.S.
BD employs nearly 30,000 associates in more than 50 countries throughout the world
Manufacturing facilities in 12 countries
ABOUT THE COMPANY
Went public in 1962
By 1996 became the largest producer of medical syringes, needles & tissue collection devices.
Larger supplier of hospital laboratory instrumentation
Products sold in 70 countries
International sales accounts for almost half of revenue.
- In United States : 5 - 15% of BDs sales to public entities
- Other than US : 50 - 90% of BDs sales to public entities
Market Leader
Diabetes-care devices - 80%
Pharmaceutical systems 70%
Hypodermic syringes 50%
ABOUT THE COMPANY
BD focuses 3 worldwide business segments:
Worlds leading suppliers of medical devices and a leading innovator in injection and infusion-based drug
BD Medical
Leading provider of products for the safe collection and transport of diagnostics specimens, as well as instruments
BD Diagnostics
World leader in bringing innovative diagnostic and research tools to life scientists, clinical researchers, laboratory professionals and clinicians
BD Biosciences
SANDEEP NAIR ROLL NO. 23
ABOUT CLATEO CASTELLINI
Chairman and CEO in 1994
Personality traits : Responsible and process oriented
Make things easier at workplace
Carries great amount of experience
Well aware of the company whereabouts
Accepts challenges, result-oriented
HIS CONCERNS
Improvement in BDs financial performance
Foresee long term goals
Achieve strong performance after crossing 100th year at BD
His main objectives
- Global perspective
Becton Dickinson as best managed & admired company
Becton Dickinson a company known for eliminating suffering & death from disease in the world
- Within the company
To reshape the companies culture
To bring ethical practices in effect.
HARDIK GANDHI ROLL NO. 8
Strength
Solid, Long standing reputation within industry
Largest producer of medical syringes, needles & tissue collection devices.
Largest supplier of hospital laboratory instrumentation
Products sold in 70 countries
Internal focus on mission and values
Weakness
Lack of standardized ethical procedures
Employees looking for greater guidance from top management regarding ethical practice to follow
Going through a stressful time of ambitious growth that presents challenges
Moving into new markets and shifting away from distributor-based sales
SWOT ANALYSIS
Opportunities
Build on existing relationships with customers and vendors worldwide
Aging populations throughout the industrial world
New Emerging markets in China & India
Become a world leader in ethical and lawful behavioral studies and education
Threats
Increased competition within industry
Cultural differences and challenges worldwide
Cope with complex legal & regulatory environment
Dynamic & fast changing market
SWOT ANALYSIS
SUMIT PANJWANI ROLL NO. 26
ISSUES
BD being an ambitious company needed new customers
Dennis Santucci was a controller of payments
Difficulty distinguishing between normal and acceptable or improper and unlawful payments
Governed under the US Foreign Corruption Practices Act
Ethical Challenges -
- A prospective customer wanted to go to training in California and visit Disneyland later with his family
- A purchasing official wanted a 2% processing fees in cash before placing the order
- A purchasing official of a new company wanted computer equipment's and refrigerator as donations
ISSUES
Paul McAuliffe, Director of Ethics and Business Practices knew employees needed guidance on such
issues.
Employees had questions about
- Acceptability of certain issues
- Gratuities
- Entertainment Costs
Solution
- Started a policy making group - Global One Company Operations
- Business heads and regional manager undertook to review the situation
- Approval on such issues by top executives
SNEHA MHATRE ROLL NO. 19
DRBC MODEL
Duties Rights
Best Practices
Commitment
DRBC MODEL
Duties Ensure best quality of medical products & equipments
Involved in advanced research, discovery of new drugs & vaccines
Legally obligated to act in a socially responsible manner
Refrain from frauds
Protect human health & safety
Business should respect, protect, and make efforts to restore the environment
Increase its shareholder wealth
DRBC MODEL
Rights
Consumers :- to get best quality medical products
Government :- to anticipate that the company abides by the law.
Society :- to expect the company to behave in socially responsible manner
Shareholder:-
- To receive notice of a shareholders' meeting
- To raise an issue related to the businesses conducted
- To expect increase in shareholder wealth
DRBC MODEL
Best Practices
BD follows
- WHO's Best Practices for Injections and Related Procedures Toolkit
- CDC's Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings
2007
Active Participants in
- Safe Injection Practices Coalition,
- United for Medical Research (UMR)
DRBC MODEL
Best Practices
Meeting Unmet Health Needs
Ensuring Good Governance and Ethics
Product Safety and Performance
Protecting the Environment
Making BD an Even Better Place to Work
DRBC MODEL
Commitments
Purpose
- Helping all people live healthy lives
BD committed to most ethical business practices
Reduce global environmental impact
Ensure that their customers n suppliers operate in ways environmentally responsible
Committed to Pink Ribbon Red Ribbon, National Cancer Coalition
SUMIT PANJWANI ROLL NO. 26
KEY TAKEAWAYS
A lot of Utilitarianism exists where results are important
A lack of Universalism exists wherein the means dont justify the ends
Thought Guidelines like Good Clinical Practises exists, various unethical practices are followed by
companies
A Stronger Government role should exist to control unethical practises
Ethics and morality to be a part of the companies value system
Companies should follow the policies and not keep it just on paper.
THANK YOU
Medical practitioners and the healthcare industry serve interests that sometimes overlap and sometimes conflict.
There is strong evidence that associations between industry and doctors influence the behavior of the latter in relation to both clinical decision making and the conduct of research.
In view of the risk of compromising relationships with patients and the integrity of the research process, doctors tend to be biased.
Clearly articulated procedures are sometimes not well developed to deal with specific issues such as travel subsidies, receipt of gifts, sponsorship of conferences and continuing education activities, and dualities of interest arising in clinical and research settings
Once technologies are directed towards making humans 'better than well', assuming the body is manipulative in nature according to individual preferences, then real ethical and theological concerns arise. The abuse of technology threatens inherent human dignity and challenges the equal moral status of all human persons
Other ethical issues are that are common in the industry : -
- When should life-sustaining treatments like breathing machines or feeding tubes be started, continued, or stopped?
- What should family members and health care professionals do if a patient refuses treatment that promises to be medically helpful?
- Who should make health care decisions for patients when they are unable to communicate or decide for themselves?
- What should patients do when they do not understand what professionals are saying and feel they are not offered the opportunity to participate in their own health care decisions?
General Ethical issues across the Industry
COMPANY : HOSPITAL CORPORATION OF AMERICA (HCA)
HCA is based out of Nashville,USA and its one of the competitors of BD.
The corporation initially had federal lobbyist and had registered lobbying presence across 12 states.
In 2000, The company had paid out a total of $1.7billion in fines, refunds and lawsuit settlements admitting that through its subsidiaries it
had -
- Offered financial incentives to doctors in violation of antikickback laws,
- falsified records to generate high payments for minor treatments or treatments that never occurred
- Charged laboratory tests that never occurred
- Charged for home-health care for patients who did not qualify for it
- Falsely labeled ads as community education
- Ever since these issues occurred, company has designed a code of conduct and enforced ethical practices in the long run ( It has
been rated as one of the best ethical company couple of years ago)
Top Related